(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 18, 2026 (GLOBE NEWSWIRE) -- "At-Home Blood Collection Kits and Devices Market Size, Share & Trends Analysis Report by Product, Application, Device Type, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering. The global at-home blood collection kits and devices market was valued at an estimated USD 193.42 million in 2025 and is projected to reach USD 381.97 million by 2033. The market is expected to expand at a compound annual growth rate of 8.92% from 2026 to 2033, supported by the rising prevalence of blood-related disorders, growing demand for preventive healthcare, rapid adoption of telehealth and remote patient monitoring, and expansion of decentralized clinical trials.
Increasing rates of anemia, iron deficiency, diabetes mellitus, and hyperlipidemia are creating sustained demand for frequent diagnostic testing and long-term health monitoring. According to the WHO 2025 report, anemia affects approximately 24.3% of the global population, representing about 1.6 billion people. In 2023, the condition affected 30.7% of women aged 15-49 and 39.8% of children aged 6-59 months worldwide.
At-home blood collection kits and devices enable repeat sample collection while reducing dependence on hospitals and diagnostic centers. These solutions support routine hemoglobin checks, platelet monitoring, coagulation testing, chronic disease management, and early detection. Research published in the Microchemical Journal in August 2025 also highlighted the value of home-based capillary blood testing in improving access to repeat diagnostics, particularly among underserved populations.
The shift toward preventive, patient-centric healthcare is further accelerating market growth. Consumers are increasingly seeking convenient tools for regular health checks, disease screening, and continuous monitoring. Integration with digital health platforms and remote physician services allows home-collected samples to support timely clinical decisions and ongoing care without requiring frequent in-person appointments.
Product innovation and regulatory progress are strengthening adoption. In April 2024, Drawbridge Health received FDA 510(k) clearance for over-the-counter use of its NanoDrop at-home blood sampling device. Its dual nano-lancet design allows users to collect whole-blood samples at home with the press of a button, supporting routine monitoring, chronic disease management, and decentralized clinical research.
Telehealth and remote patient monitoring are also increasing demand for reliable home-collected blood samples. At-home solutions, including finger-prick kits, specialized collection cards, on-arm devices, and optional professional phlebotomy services, help healthcare providers monitor patients remotely while reducing travel requirements and wait times. Technologies such as Tasso, RedDrop, and Capitainer SEP10 cards are contributing to improved patient engagement and clinical efficiency. The American Telemedicine Association's Home Testing Special Interest Group, launched in September 2021, continues to promote the integration of home diagnostic testing with virtual care.
Decentralized clinical trials represent another important market opportunity. Remote monitoring, telemedicine visits, eConsent, and at-home sample collection can improve participant access, recruitment, retention, and study efficiency. A 2026 analysis published in PLOS Digital Health documented continued growth in decentralized clinical trials registered through ClinicalTrials.gov. As pharmaceutical companies and contract research organizations increase the use of decentralized and hybrid study models, demand is expected to rise for high-quality blood collection technologies that can reliably support clinical endpoints outside traditional research sites.
Market Segmentation
The report provides global, regional, and country-level revenue forecasts and analyzes industry trends across key sub-segments from 2021 to 2033.
Product Outlook (Revenue, USD Million, 2021-2033)
Dried Blood Spot (DBS) Kits Micro-sampling Devices Fingerstick Blood Collection Kits Lancets Capillary Blood Collection Tubes Others
Application Outlook (Revenue, USD Million, 2021-2033)
Chronic disease monitoring Infectious disease testing Genetic & hormonal testing Preventive health/wellness
Device Type Outlook (Revenue, USD Million, 2021-2033)
Self-Collection Devices Professional-assisted home devices
Regional Outlook (Revenue, USD Million, 2021-2033)
North America: U.S., Canada, and Mexico Europe: UK, Germany, France, Italy, Spain, Denmark, Sweden, and Norway Asia Pacific: China, Japan, India, Australia, Thailand, and South Korea Latin America: Brazil and Argentina Middle East & Africa: South Africa, Saudi Arabia, UAE, and Kuwait
Key Benefits of the Report
Detailed market estimates and forecasts across major products, applications, device types, countries, and regions Analysis of market drivers, emerging trends, growth opportunities, and competitive strategies Assessment of key companies, market presence, and product innovation Actionable intelligence to support investment planning, market entry, and revenue growth decisions Segment and regional revenue forecasts designed to strengthen strategic market assessment
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment